Found 9 results
Name | Type of Offering | Accepted Date |
---|---|---|
GT Biopharma, Inc.
|
D | 2018-08-17 16:42:34 |
Amount To Be Raised
$5,140,000
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0001654954-18-009332
Exclusions or Exemptions
506b
Accepted Date
2018-08-17 16:42:34
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
FLORIDA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
OXIS INTERNATIONAL INC
|
D | 2014-07-31 |
Amount To Be Raised
$1,425,000
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0001250853-14-000096
Exclusions or Exemptions
506b
Accepted Date
2014-07-31
Type of Offering
D
Industry
Other Health Care
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
$1 - $1,000,000
Type of Security
Debt
|
||
GT Biopharma, Inc.
|
D | 2018-02-06 17:29:57 |
Amount To Be Raised
$7,055,000
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0001654954-18-001133
Exclusions or Exemptions
506b
Accepted Date
2018-02-06 17:29:57
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DISTRICT OF COLUMBIA
Revenue or Assets
$1 - $1,000,000
Type of Security
Debt
|
||
GT Biopharma, Inc.
|
D | 2020-06-12 16:46:17 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0001654954-20-006561
Exclusions or Exemptions
506b
Accepted Date
2020-06-12 16:46:17
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|
||
GT Biopharma, Inc.
|
D | 2017-09-14 17:01:12 |
Amount To Be Raised
$4,540,000
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0000939798-17-000077
Exclusions or Exemptions
506b
Accepted Date
2017-09-14 17:01:12
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
DISTRICT OF COLUMBIA
Revenue or Assets
$1 - $1,000,000
Type of Security
Equity
|
||
GT Biopharma, Inc.
|
D | 2025-03-07 17:29:24 |
Amount To Be Raised
$1,280,358
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0000109657-25-000002
Exclusions or Exemptions
506b
Accepted Date
2025-03-07 17:29:24
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
OXIS INTERNATIONAL INC
|
D | 2015-03-13 |
Amount To Be Raised
$3,000,000
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0000939798-15-000012
Exclusions or Exemptions
506b
Accepted Date
2015-03-13
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
FLORIDA
Revenue or Assets
$1 - $1,000,000
Type of Security
Equity
|
||
OXIS INTERNATIONAL INC
|
D | 2015-07-24 |
Amount To Be Raised
$1,500,000
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0000939798-15-000050
Exclusions or Exemptions
506b
Accepted Date
2015-07-24
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
FLORIDA
Revenue or Assets
$1 - $1,000,000
Type of Security
Equity
|
||
GT Biopharma, Inc.
|
D/A | 2020-07-23 17:00:37 |
Amount To Be Raised
Indefinite
Associated Brokers / Dealers
N/A
CIK Number
0000109657
Filed Document
0001654954-20-007958
Exclusions or Exemptions
506b
Accepted Date
2020-07-23 17:00:37
Type of Offering
D/A
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Debt
|